Physician profile
Stephen Wright
NPI 1053901934
$872.37
in general payments reported to CMS, 2019-2025
15 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.76 · 2023: $372 · 2024: $223 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $188.69 | 2024-2025 | Assure Wcd |
| Amgen INC. | $137.43 | 2022-2024 | Repatha |
| Pfizer INC. | $112.76 | 2022-2025 | |
| Medtronic, INC. | $73.80 | 2024 | Micra |
| Atricure, INC. | $73.18 | 2023 | |
| Baxter Healthcare | $63.75 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $45.03 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $38.15 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $28.25 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.44 | 2023 | |
| Impulse Dynamics (USA) INC. | $22.95 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $18.46 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $14.92 | 2024 | Camzyos |
| Scpharmaceuticals INC. | $14.72 | 2023 | |
| Janssen Pharmaceuticals, INC | $12.84 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.